Wolfgangrene's charts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Wolfgangrene's charts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Ox who wrote (1057)	5/28/2015 4:11:07 PM
From: ItsAllCyclical	Read Replies (1) of 3976

Big 4 in biotech land are really not all that expensive. They could care less about rising interest rates or the global economy. Biggest downside is political action on drug costs which have become obscene. You're shorting on valuation not on a structural change or some other catalyst. Some individual names look shortable but you have to have the knowledge to and then you have to find something that doesn't have a high short interest. Long term I think EXAS will go down, but with 40% short interest no thanks. Easier places to make a buck. Breakout on FEYE today. Let's see if it continues. Just started looking at WYNN and that space.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next